Profile
CHEK DHR-PB TMO DHR IQV A
Company Name Check-Cap Ltd. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $13.46M $916.76B $219.48B $182.87B $42.40B $40.64B
Employees 0.09K 79.00K 122.00K 61.00K 87.00K 17.70K
CEO Mr. Alex Ovadia Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Michael R. McMullen
Ratings
CHEK DHR-PB TMO DHR IQV A
Quant Rating Score 2 5 5 4 5 5
Quant Rating Sell Strong Buy Strong Buy Buy Strong Buy Strong Buy
Trading
CHEK DHR-PB TMO DHR IQV A
Last Close $2.3 $1261.26 $574.99 $246.89 $232.94 $138.69
High 52 $4.5 $1261.26 $599.43 $265.59 $259.1 $148.04
Low 52 $1.31 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High -48.89 % 0 % -4.08 % -7.04 % -10.1 % -6.32 %
Price vs. 52 Week Low 75.57 % 0 % 33.28 % 33.38 % 31.49 % 37.09 %
Total Return
CHEK DHR-PB TMO DHR IQV A
1 Month Return -12.88 % 0 % 0.6 % 0.39 % -5.12 % -3.8 %
3 Month Return 7.98 % 0 % 4.2 % 0.23 % 10.53 % 4.3 %
6 Month Return -32.94 % 0 % 28.47 % 27.94 % 22.3 % 32.76 %
9 Month Return -28.35 % 0 % 3.83 % -4.26 % 6.32 % 8.6 %
YTD Return 10.58 % 0 % 8.33 % 6.72 % 0.67 % -0.24 %
1 Year Return 71.64 % 0 % 5.73 % 1.69 % 25.51 % 3.1 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CHEK DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.43 % 0.25 % 0.43 % - 0.66 %
Dividend Paid and Capex Coverage Ration (TTM) -101.68 % 3.16 % 4.68 % 2.65 % 3.31 % 3.39 %
Dividend Per Share (TTM) - 1.05 % 1.44 % 1.05 % - 0.92 %
Payout Ratio (TTM) - 17.87 % 8.96 % 27.74 % - 21.6 %
Growth
CHEK DHR-PB TMO DHR IQV A
Asset Growth -18.36 % 0.16 % 1.62 % 0.16 % 5.3 % 2.35 %
Gross Profit Growth -97.56 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth - -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year - 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year - 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year - 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth -15.66 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth -12.65 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share 90.03 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share 97.47 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share 97.73 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth -15.66 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) -15.02 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 89.75 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG 97.38 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG 98.03 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth 17.92 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth 17.92 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -40.51 % 5.14 % 7.9 % 5.14 % 8.21 % 12.39 %
Share Holder 3 Year Equity Growth Per Share -53.35 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -91.03 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share -96.47 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % - 7.8 %
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % - 25.46 %
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % -100 % 97.03 %
Debt Growth -15.81 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth -11.13 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
CHEK DHR-PB TMO DHR IQV A
Gross Profit Margin TTM - 58.45 % 40.11 % 58.4 % 33.04 % 50.63 %
Return on Assets TTM -60.8 % 5.33 % 6.22 % 5.28 % 5.09 % 11.29 %
Return on Equity TTM -51.94 % 8.42 % 13.33 % 8.34 % 23.02 % 21.15 %
Return on Capital Employed TTM -70.88 % 7.39 % 8.4 % 5.54 % 10.08 % 14.19 %
Net Income Per EBT TTM 100.16 % 83.98 % 92.6 % 97.45 % 93.08 % 92.79 %
EBT Per Ebit TTM 90.76 % 94.74 % 93.36 % 107.86 % 71.7 % 100.6 %
EBIT Per Revenue TTM - 21.3 % 16.45 % 18.6 % 13.54 % 19.66 %
Cash Flow To Debt Ratio TTM -58540 % 36.11 % 25.07 % 36.11 % 15.6 % 75.39 %
Receivables Turnover TTM - 7.76 5.36 6.66 4.4 5.2
Payables Turnover TTM 1.76 6.49 - 5.58 2.82 6.81
Inventory Turnover TTM - 4.12 4.96 3.54 - 3.22
Fixed Asset Turnover TTM - 463.28 % 455.73 % 397.72 % 1834.55 % 458.48 %
Asset Turnover TTM - 31.45 % 43.76 % 27 % 56.31 % 61.52 %
Operating Cash Flow Per Share TTM -3 9.27 23.37 9.39 11.81 6.69
Free Cash Flow Per Share TTM -3.03 7.39 19.79 7.5 8.25 5.63
Cash Per Share TTM 479.8 % 937.04 % 1897.91 % 949.37 % 822.43 % 596.59 %
Operating Cash Flow Sales Ratio TTM - 26.52 % 21.01 % 30.89 % 14.3 % 29.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.98 % 79.76 % 84.68 % 79.89 % 69.8 % 84.09 %
Cash Flow Coverage Ratios TTM -58540 % 36.11 % 25.07 % 36.11 % 15.6 % 75.39 %
Price To Free Cash Flows Ratio TTM -0.76 32.96 29.03 32.91 28.27 24.65
Price To Operating Cash Flows Ratio TTM -0.77 26.63 24.6 26.29 19.72 20.72
Price Cash Flow Ratio TTM -0.77 26.63 24.6 26.29 19.72 20.72
Income Statement (TTM)
CHEK DHR-PB TMO DHR IQV A
Revenue $0B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $-0B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 0% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.02B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $-0.02B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -3.39 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
CHEK DHR-PB TMO DHR IQV A
Long Term Debt $0B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $0B $31B $51.88B $31B $20.57B $4.92B
Total Equity $0.04B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0.04B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.05B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
CHEK DHR-PB TMO DHR IQV A
Net Income $-0.02B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $0B $-0.27B
Operating Cash Flow $-0.02B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 138.69
ACRS Aclaris Therapeutics, Inc. 1.26
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 4.03
AWH Aspira Women's Health Inc. 3.22
BDSX Biodesix, Inc. 1.25
BIAF bioAffinity Technologies, Inc. 2.45
BIAFW bioAffinity Technologies, Inc. 0.3547
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.9585
BNR Burning Rock Biotech Limited 0.7478
CDNA CareDx, Inc 9.18
CEMI Chembio Diagnostics, Inc. 0.455
CNTG Centogene N.V. 0.44
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 232.69
CSTL Castle Biosciences, Inc. 22.02
DGX Quest Diagnostics Incorporated 137.55
DHR Danaher Corporation 246.89
DHR-PA Danaher Corporation 1841.01
Unlock